Skip to main content

Inari Medical, Inc.

NARIDelisted Feb 19, 2025
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531048

Inari Medical, Inc. was delisted on Feb 19, 2025; its insiders filed their last Form 4 on Feb 19, 2025; 258 institutions reported holding it in 13F filings for Q4 2024, worth $2.80B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Inari Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Inari Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Inari Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Mead Dana G Jr.Director0Feb 19, 20250
Root Jonathan DDirector0IndirectFeb 19, 20250
Milder Donald BDirector0IndirectFeb 19, 20250
Hoffman WilliamDirector0Feb 19, 20250
Lucchese Cynthia LDirector0Feb 19, 20250
Szyman Catherine M.Director0Feb 19, 20250
Tu ThomasChief Medical Officer0Feb 19, 20250
Hykes AndrewPresident and CEO0Feb 19, 20250
Chambers RebeccaDirector0Feb 19, 20250
Warner Robert KeithDirector0Feb 19, 20250
Strange Kevin TChief Financial Officer0Feb 19, 20250
Silva KarenPrincipal Accounting Officer0Feb 19, 20250
Hill, Mitch C.Chief Financial Officer177,533Oct 2, 20240
Nielsen Kirk G.Director61,479May 30, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 7, 2021 (view filing)Jul 61 dayHoffman WilliamPresident and CEOSSale−60.1K$94.22−$5.66M−6.7%831.0K after5 lots
Jul 7, 2021 (view filing)Jul 7Same dayHoffman WilliamPresident and CEOSSale−69.9K$91.48−$6.40M−8.4%760.6K after6 lots
Jul 12, 2021 (view filing)Jul 93 daysMilder Donald BDirector, 10% OwnerSSale−7.00K$92.72−$649.0K−0.2%4.56M after4 lots
Jul 12, 2021 (view filing)7:44 PM ETJul 93 daysHill, Mitch C.Chief Financial OfficerSSale−5.00K$92.71−$463.5K−6.9%67.7K after4 lots
Jul 20, 2021 (view filing)Jul 191 dayHykes AndrewChief Operating OfficerSSale−9.00K$85.21−$766.9K−4.6%187.2K after4 lots
Jul 28, 2021 (view filing)1:28 PM ETJul 271 dayTu ThomasChief Medical OfficerSSale−5.00K$84.20−$421.0K−9.3%48.9K after4 lots
Aug 6, 2021 (view filing)Aug 51 dayHoffman WilliamPresident and CEOSSale−30.0K$93.33−$2.80M−3.9%730.8K after3 lots
Aug 10, 2021 (view filing)1:35 PM ETAug 91 dayHill, Mitch C.Chief Financial OfficerSSale−5.00K$95.16−$475.8K−6.9%67.9K after3 lots
Aug 11, 2021 (view filing)Aug 101 dayMilder Donald BDirectorSSale−7.00K$90.64−$634.5K−0.2%4.55M after6 lots
Aug 19, 2021 (view filing)Aug 19Same dayHykes AndrewChief Operating OfficerSSale−9.00K$72.65−$653.9K−4.8%178.2K after2 lots
Aug 30, 2021 (view filing)5:39 PM ETAug 273 daysTu ThomasChief Medical OfficerSSale−5.00K$81.31−$406.5K−9.3%48.9K after3 lots
Sep 8, 2021 (view filing)Sep 71 dayHoffman WilliamPresident and CEOSSale−30.0K$81.57−$2.45M−4.1%700.8K after3 lots
Sep 10, 2021 (view filing)Sep 10Same dayMilder Donald BDirectorSSale−7.00K$81.02−$567.1K−0.2%4.54M after3 lots
Sep 10, 2021 (view filing)6:58 PM ETSep 91 dayHill, Mitch C.Chief Financial OfficerSSale−5.00K$82.00−$410.0K−5.4%87.9K after3 lots
Sep 17, 2021 (view filing)Sep 17Same dayHykes AndrewChief Operating OfficerSSale−9.00K$80.75−$726.8K−5.1%169.2K after2 lots
Sep 28, 2021 (view filing)8:12 PM ETSep 271 dayTu ThomasChief Medical OfficerSSale−5.00K$82.86−$414.3K−9.3%48.9K after3 lots
Oct 6, 2021 (view filing)Oct 5-61 dayHoffman WilliamPresident and CEOSSale−70.1K$78.97−$5.54M−10.0%630.3K after3 lots
Oct 7, 2021 (view filing)Oct 7Same dayHoffman WilliamPresident and CEOSSale−29.9K$81.10−$2.42M−4.7%600.4K after2 lots
Oct 12, 2021 (view filing)Oct 84 daysMilder Donald BDirectorSSale−7.00K$79.33−$555.3K−0.2%4.54M after3 lots
Oct 12, 2021 (view filing)4:49 PM ETOct 84 daysHill, Mitch C.Chief Financial OfficerSSale−5.00K$79.31−$396.6K−5.4%87.7K after3 lots
Oct 20, 2021 (view filing)Oct 191 dayHykes AndrewChief Operating OfficerSSale−9.00K$87.76−$789.9K−5.3%159.8K after4 lots
Oct 21, 2021 (view filing)Oct 201 dayHoffman WilliamPresident and CEOSSale−25.8K$90.10−$2.32M−4.3%574.6K after
Oct 27, 2021 (view filing)Oct 252 daysHoffman WilliamPresident and CEOSSale−500$90.05−$45.0K−0.1%574.1K after
Oct 28, 2021 (view filing)Oct 28Same dayHoffman WilliamPresident and CEOSSale−3.72K$90.17−$335.6K−0.6%570.4K after
Oct 28, 2021 (view filing)9:43 PM ETOct 271 dayTu ThomasChief Medical OfficerSSale−5.00K$87.68−$438.4K−9.3%48.6K after2 lots
Nov 9, 2021 (view filing)Nov 54 daysHoffman WilliamPresident and CEOSSale−30.0K$91.22−$2.74M−5.3%540.4K after5 lots
Nov 12, 2021 (view filing)Nov 102 daysMilder Donald BDirectorSSale−7.00K$92.56−$648.0K−0.2%4.53M after3 lots
Nov 12, 2021 (view filing)5:10 PM ETNov 93 daysHill, Mitch C.Chief Financial OfficerSSale−5.00K$86.82−$434.1K−5.4%87.7K after2 lots
Dec 1, 2021 (view filing)7:36 PM ETNov 292 daysTu ThomasChief Medical OfficerSSale−5.00K$83.40−$417.0K−7.9%58.6K after4 lots
Dec 8, 2021 (view filing)Dec 62 daysHoffman WilliamPresident and CEOSSale−60.0K$78.63−$4.72M−11.1%480.4K after7 lots
Dec 13, 2021 (view filing)Dec 103 daysMilder Donald BDirectorSSale−7.00K$79.00−$553.0K−0.2%4.52M after3 lots
Dec 17, 2021 (view filing)Dec 152 daysHill, Mitch C.Chief Financial OfficerSSale−20.0K$79.04−$1.58M−22.8%67.7K after4 lots
Dec 17, 2021 (view filing)Dec 152 daysHykes AndrewChief Operating OfficerSSale−22.2K––−13.9%137.6K after
Jan 6, 2022 (view filing)Jan 42 daysHoffman WilliamPresident and CEOSSale−30.0K$94.05−$2.82M−6.3%449.8K afterFrom original7 lots
Jan 20, 2022 (view filing)Jan 182 daysHykes AndrewChief Operating OfficerSSale−5.00K$76.65−$383.2K−3.2%153.0K after4 lots
Jan 20, 2022 (view filing)8:05 PM ETJan 182 daysHill, Mitch C.Chief Financial OfficerSSale−7.50K$76.67−$575.0K−10.0%67.8K after4 lots
Feb 3, 2022 (view filing)Feb 12 daysHykes AndrewChief Operating OfficerSSale−5.00K$73.67−$368.4K−3.3%148.1K after4 lots
Feb 9, 2022 (view filing)7:57 PM ETFeb 72 daysHoffman WilliamPresident and CEOSSale−30.0K$74.01−$2.22M−5.3%538.7K after4 lots
Feb 11, 2022 (view filing)Feb 92 daysMilder Donald BDirectorSSale−400$80.06−$32.0K0.0%3.89M after
Feb 17, 2022 (view filing)Feb 15-162 daysMilder Donald BDirectorSSale−9.33K$80.06−$746.8K−0.2%3.88M after2 lots
Feb 17, 2022 (view filing)6:41 PM ETFeb 152 daysHill, Mitch C.Chief Financial OfficerSSale−7.50K$79.10−$593.2K−10.0%67.8K after2 lots
Feb 25, 2022 (view filing)Feb 23-242 daysMilder Donald BDirectorSSale−4.27K$80.06−$342.0K−0.1%3.88M after3 lots
Mar 2, 2022 (view filing)Feb 28-Mar 12 daysHykes AndrewChief Operating OfficerSSale−20.0K$90.35−$1.81M−11.2%158.0K after10 lots
Mar 2, 2022 (view filing)6:24 PM ETFeb 28-Mar 12 daysTu ThomasChief Medical OfficerSSale−4.00K$90.01−$360.1K−4.9%78.3K after3 lots
Mar 9, 2022 (view filing)5:08 PM ETMar 72 daysHoffman WilliamPresident and CEOSSale−60.0K$95.48−$5.73M−10.6%508.7K after14 lots
Mar 17, 2022 (view filing)6:02 PM ETMar 152 daysHill, Mitch C.Chief Financial OfficerSSale−7.50K$75.54−$566.5K−7.9%87.7K after3 lots
Mar 18, 2022 (view filing)Mar 162 daysMilder Donald BDirectorSSale−7.00K$80.18−$561.3K−2.9%237.2K after
Mar 18, 2022 (view filing)Jun 22, 2020-Nov 15, 2021634 daysLateRoot Jonathan DDirectorPPurchase+335$85.02+$28.5KNew position335 after2 lots
Mar 30, 2022 (view filing)4:33 PM ETMar 282 daysTu ThomasChief Medical OfficerSSale−2.00K$90.00−$180.0K−2.5%78.5K after
Apr 5, 2022 (view filing)Apr 14 daysHykes AndrewChief Operating OfficerSSale−10.0K$91.16−$911.6K−6.0%157.0K after5 lots